Malignant melanoma and Wiedemann-Beckwith syndrome in childhood

Klinische Padiatrie

Volumn 222, Issue 6, 2010, Pages 388-390

  Livingstone, E ^a   Caliebe, A ^b   Egberts, F ^b   Proksch, E ^b   Buiting, K ^a   Schubert, C ^c   Claviez, A ^b   Siebert, R ^b   Hauschild, A ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c Institute of Dermatology   (Germany)

Author keywords

Genomic imprinting; Malignant melanoma; Tumor predisposition; Wiedemann Beckwith syndrome

Indexed keywords

MELAN A; MONOCLONAL ANTIBODY HMB 45; PEGINTERFERON ALPHA2B; POTASSIUM CHANNEL KCNQ1; PROTEIN S 100; RECOMBINANT ALPHA2B INTERFERON; RNA H19; SOMATOMEDIN B;

ADOLESCENT; ARTICLE; BECKWITH WIEDEMANN SYNDROME; BODY HEIGHT; CASE REPORT; CHROMOSOME 11P; CLINICAL FEATURE; CONTROLLED STUDY; DNA EXTRACTION; DNA METHYLATION; DOSE RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FAMILY HISTORY; FATIGUE; FLU LIKE SYNDROME; GENE MUTATION; GENETIC ANALYSIS; HIGH BIRTH WEIGHT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LOW DRUG DOSE; LYMPH NODE BIOPSY; MALE; MELANOMA; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; REGULATOR GENE; VERRUCA VULGARIS;

ADOLESCENT; BECKWITH-WIEDEMANN SYNDROME; CHEEK; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; FACIAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; GENOMIC IMPRINTING; HUMANS; MALE; MELANOMA; RNA, UNTRANSLATED; SKIN NEOPLASMS;

EID: 78349296755     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1267152     Document Type: Article

References (21)

1. Brecht IB, Graf N, Schweinitz D, etal. Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klin Pädiatr 2009 221 181-185
2. Certa U, Seiler M, Padovan E, etal. High density oligonucleotide array analysis of interferon-alpha2a sensitivity and transcriptional response in melanoma cells. Br J Cancer 2001 85 107-114
3. Certa U, Seiler M, Padovan E, etal. Interferon-a sensitivity in melanoma cells: detection of potential response marker genes. Recent Results Cancer Res 2002 160 85-91
4. Downard CD, Rapkin LB, Gow KW. Melanoma in children and adolescents. Surg Oncol 2007 16 215-220
5. Elliott M, Maher ER. Beckwith-Wiedemann syndrome. J Med Genet 1994 31 560-564
6. Engel JR, Smallwood A, Harper A, etal. Epigenotype-phenotype correlations in Beckwith-Wiedemann syndrome. J Med Genet 2000 37 921-926
7. Frühwald MC, Witt O. The epigenetics of cancer in children. Klin Pädiatr 2008 220 333-341
8. Goldstein AM, Fraser MC, Struewing JP, etal. Increased risk of pancreatic cancer in melanoma-prone kindreds with p16INK4 mutations. N Engl J Med 1995 333 970-974
9. Hamre MR, Chuba P, Bakhshi S, etal. Cutaneous melanoma in childhood and adolescence. Pediatr Hematol Oncol 2002 19 309-317
10. Higurashi M, Iijima K, Sugimoto Y, etal. The birth prevalence of malformation syndromes in Tokyo infants: a survey of 14430 newborn infants. Am J Med Genet 1980 6 189-194
11. Lam WW, Hatada I, Ohishi S, etal. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation. J Med Genet 1999 36 518-523
12. Lee SK, Kang JS, Jung dJ, etal. Vitamin C suppresses proliferation of the human melanoma cell SK-MEL-2 through the inhibition of cyclooxygenase-2 (COX-2) expression and the modulation of insulin-like growth factor II (IGF-II) production. J Cell Physiol 2008 216 180-188
13. Pos Z, Wiener Z, Pocza P, etal. Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma. Cancer Res 2008 68 1997-2005
14. Pryor JG, Bourne PA, Yang Q, etal. IMP-3 is a novel progression marker in malignant melanoma. Mod Pathol 2008 21 431-437
15. Rump P, Zeegers MP, van Essen AJ. Tumor risk in Beckwith-Wiedemann syndrome: A review and meta-analysis. Am J Med Genet A 2005 136 95-104
16. Schmid-Wendtner MH, Berking C, Baumert J, etal. Cutaneous melanoma in childhood and adolescence: an analysis of 36 patients. J Am Acad Dermatol 2002 46 874-879
17. Soares MR, Huber J, Rios AF, etal. Investigation of IGF2/ApaI and H19/RsaI polymorphisms in patients with cutaneous melanoma. Growth Horm IGF Res 2010 20 295-297
18. Weksberg R, Nishikawa J, Caluseriu O, etal. Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet 2001 10 2989-3000
19. Wiedemann HR. Familial malformation complex with umbilical hernia and macroglossia a new syndrome? J Genet Hum 1964 13 223-232
20. Wiedemann HR. Frequency of Wiedemann-Beckwith syndrome in Germany; rate of hemihyperplasia and of tumours in affected children. Eur J Pediatr 1997 156 251
21. Yu L, Xu H, Wasco MJ, etal. IMP-3 expression in melanocytic lesions. J Cutan Pathol 2010 37 316-322